MedPath
NMPA Approval

Ceftizoxime Sodium for Injection

国药准字H20249278

November 5, 2024

Drug Information

注射用头孢唑肟钠

注射剂

0.5g(按C₁₃H₁₃N₅O₅S₂计)

化学药品

November 5, 2024

Company Information

Applicant Company

重庆市北碚区水土街道云汉大道117号附923号

Manufacturing Company

重庆市南岸经济技术开发区大石支路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用头孢唑肟钠 - NMPA 批准文号 | MedPath